AGIO

Agios Pharmaceuticals, Inc. - Common Stock (AGIO)

About Agios Pharmaceuticals, Inc. - Common Stock (AGIO)

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

Details

Daily high

$34.14

Daily low

$33.30

Price at open

$33.70

52 Week High

$46.00

52 Week Low

$22.24

Market cap

2.0B

Dividend yield

Volume

819,497

Avg. volume

861,157

P/E ratio

-4.72

Agios Pharmaceuticals, Inc. - Common Stock News